Patents for A61P 35 - Antineoplastic agents (221,099) |
---|
12/19/2012 | EP2535357A1 Novel antibodies inhibiting C-MET dimerization, and uses thereof |
12/19/2012 | EP2535356A1 Novel antibodies inhibiting C-MET dimerization, and uses thereof |
12/19/2012 | EP2535355A2 Antibodies against CD38 for treatment of multiple myeloma |
12/19/2012 | EP2535354A1 Antibodies to human programmed death receptor PD-1 |
12/19/2012 | EP2535353A1 Monoclonal antibodies that bind to hGM-CSF and medical compositions comprising same |
12/19/2012 | EP2535345A1 Anticancer nucleoside analogs |
12/19/2012 | EP2535342A1 Salt of fused heterocyclic derivative and crystal thereof |
12/19/2012 | EP2535339A1 Polymorphs of dasatinib, preparation methods and pharmaceutical compositions thereof |
12/19/2012 | EP2535337A1 Crystalline forms of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide sulfate and its amorphous form |
12/19/2012 | EP2535059A1 Use of compound binding to msin3b that specifically binds to neuron restrictive silencer factor (nrsf) |
12/19/2012 | EP2535055A1 Oncolytic virotherapy for therapy of bone cancer |
12/19/2012 | EP2535052A1 Method for producing nk cell enhancement-type blood product |
12/19/2012 | EP2534170A1 Iap bir domain binding compounds |
12/19/2012 | EP2534156A1 7-aminofuropyridine derivatives |
12/19/2012 | EP2534153A1 Salts and polymorphs of 8-fluoro-2-{4-[(methylamino}methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one |
12/19/2012 | EP2534149A1 6-amino-2-{ [ (1s)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)-7,9-dihydro-8h-purin-8-one maleate |
12/19/2012 | EP2534148A1 Purine derivatives and their pharmaceutical uses |
12/19/2012 | EP2534145A2 Therapeutic methods and compositions involving allosteric kinase inhibition |
12/19/2012 | EP2534138A1 1,2,3-triazole-based peptidomimetic integrin inhibitors for the diagnosis and therapy of tumors |
12/19/2012 | EP2534132A1 Substituted pyrrolidine-2-carboxamides |
12/19/2012 | EP2534131A1 Methods of synthesizing and isolating n-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same |
12/19/2012 | EP2533859A1 Pharmaceutical compositions and methods for the treatment and prevention of cancer |
12/19/2012 | EP2533817A2 Alpha-emitting complexes |
12/19/2012 | EP2533810A1 Cd20 antibodies and uses thereof |
12/19/2012 | EP2533806A2 Methods and materials for treating cancer |
12/19/2012 | EP2533795A2 THE USE OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AND PACAP ANALOGS AS ADJUNCTIVE TREATMENTS WITH INHIBITORS OF CALCINEURIN OR INHIBITORS OF THE MAMMALIAN TARGET OF RAPAMYCIN (mTOR) COMPLEXES |
12/19/2012 | EP2533781A2 Method for treating hematological cancers |
12/19/2012 | EP2533779A2 Alpha-methyl-tryptophan as an inhibitor of indoleamine dioxygenase |
12/19/2012 | EP2533778A1 Tryptophan hydroxylase inhibitors for the treatment of metastatic bone disease |
12/19/2012 | EP2533775A1 Carbonic anhydrase inhibitors |
12/19/2012 | EP2268652B1 Platinum-n-heterocyclic carbene derivatives, preparation thereof and therapeutic use thereof |
12/19/2012 | CN102834514A Transformation plasmid |
12/19/2012 | CN102834513A Antiviral therapeutic agents |
12/19/2012 | CN102834512A Metal salen complex derivative and process for production thereof |
12/19/2012 | CN102834414A Antibodies against csf-1r |
12/19/2012 | CN102834389A Dimeric iap inhibitors |
12/19/2012 | CN102834382A Pyrazole derivatives as modulators of calcium release-activated calcium channel |
12/19/2012 | CN102834113A Pharmaceutical composition for treating and/or preventing cancer |
12/19/2012 | CN102834100A Use of novel pan-cdk inhibitors for treating tumors |
12/19/2012 | CN102834098A Use of benzo-heterocycle derivatives for preventing and treating cancer or for inhibiting cancer metastasis |
12/19/2012 | CN102834097A Purified pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same |
12/19/2012 | CN102834094A Combination of organic compounds |
12/19/2012 | CN102827843A Orail gene-oriented short hairpin ribonucleic acid (shRNA) for inhibiting tumor proliferation and metastasis, and application thereof |
12/19/2012 | CN102827840A SiRNA inhibiting PPFIA1 gene expression, and its application |
12/19/2012 | CN102827813A Anti-human CD133 monoclonal antibody and preparation method and applications thereof |
12/19/2012 | CN102827809A Preparation method of CIK (Cytokine Induced Killer) cells with high proliferation capacity, high cytotoxic activity and high survival rate, associated CIK cells and application |
12/19/2012 | CN102827298A Uniform polysaccharide of ganoderma sinensis liquid deep layer fermentation mycelium, and preparation method thereof |
12/19/2012 | CN102827297A Uniform polysaccharide obtained from ganoderma sinensis liquid deep layer fermentation mycelium, and preparation method thereof |
12/19/2012 | CN102827287A Compositions and methods for diagnosing and treating cancer |
12/19/2012 | CN102827282A Human resistant Trop-2 genetically engineered antibody immunoglobulin G (IgG) and application thereof |
12/19/2012 | CN102827280A Anti-IL-13 antibodies and use thereof |
12/19/2012 | CN102827272A Folate coupling antibody drug and its preparation method and use |
12/19/2012 | CN102827269A Thymulin alpha 1 analog and preparation method thereof |
12/19/2012 | CN102827266A Application of ligand antrum mucosal protein-18(AMP-18) of laminin receptor in treatment of tumor |
12/19/2012 | CN102827257A Peptide fragment of gp96 protein and applications thereof |
12/19/2012 | CN102827228A Silicon phthalocyanine modified by cytidine derivative and preparation method and application thereof |
12/19/2012 | CN102827227A Silicon phthalocyanine modified by adenosine derivative and preparation method and application thereof |
12/19/2012 | CN102827226A Silicon phthalocyanine modified by uridine derivatives and preparation method and application of silicon phthalocyanine |
12/19/2012 | CN102827223A Di-pyrimidine base tricyclic nucleoside compound, and synthetics method and pharmaceutical use thereof |
12/19/2012 | CN102827210A Naphthol aldehyde Schiff alkali cobalt coordination polymer and preparation method and application thereof |
12/19/2012 | CN102827186A Pyridino five-membered heterocyclic derivative as well as preparation method and applications thereof |
12/19/2012 | CN102827170A Active treatment compositions and use method thereof |
12/19/2012 | CN102827167A Octahydro-pyrrolo[3,4-b]pyrrole derivatives and use of octahydro-pyrrolo[3,4-b]pyrrole derivatives as histamine-3 receptor |
12/19/2012 | CN102827160A PI3K or PI3K/m-TOR pathway inhibitor and pharmaceutical applications thereof |
12/19/2012 | CN102827151A 7-methoxy-2, 8-bis (3-methylbut-2-enyl) xanthone-1, 3, 6-triyl tripyrazine-2-carboxylate, and semi-synthesis method and medicinal application thereof |
12/19/2012 | CN102827142A Quinoline-8-formamide compound as well as preparation method and applications thereof |
12/19/2012 | CN102827132A Alpha-mangostin amino-acid ester derivative, as well as preparation method and application thereof |
12/19/2012 | CN102827124A Coumarins derivate and medicine composition thereof and application |
12/19/2012 | CN102827116A Alpha-aryl-gamma-methylene butene lactone compounds, and synthesis method and application thereof |
12/19/2012 | CN102827073A Therapeutically active compositions and application methods thereof |
12/19/2012 | CN102827061A 5,6,7- trimethoxy indole derivative, preparation method and use thereof |
12/19/2012 | CN102827050A Methylene-thiosemicarbazone-based substituted phenoxy carboxylic acid derivative, and preparation method and application thereof |
12/19/2012 | CN102827049A (Thiosemicarbazideformyl) phenoxyacetic acid derivative and application thereof |
12/19/2012 | CN102826524A Mesoporous hydroxyapatite nonoparticles prepared by microwave-ultrasonic method, and application thereof |
12/19/2012 | CN102824646A Conjugate of polyethylene glycol interferon |
12/19/2012 | CN102824637A Application of TRPC5 as drug target in reversing multi-drug resistance |
12/19/2012 | CN102824636A Pharmaceutical composition containing statins and polyunsaturated fatty acid and application thereof |
12/19/2012 | CN102824629A Immune hematogenesis anti-cancer preparation for treating leukemia and preparation method thereof |
12/19/2012 | CN102824614A Application of Wujin tablets for preparing medicines for suppressing PC-3 cell proliferation |
12/19/2012 | CN102824607A Traditional Chinese medicine composition for inhibiting vasculogenic mimicry and angiogenesis of intestinal cancer and application thereof |
12/19/2012 | CN102824606A Medicine for treating intestinal cancer and inhibiting formation of vascular mimicry of intestinal cancer and application of medicine |
12/19/2012 | CN102824605A Traditional Chinese medicine for treating gastric cancer |
12/19/2012 | CN102824595A Traditional Chinese medicine composition for treating cancer ache |
12/19/2012 | CN102824580A Panax notoginseng potassium iodide tablets |
12/19/2012 | CN102824543A Yew anti-cancer paste |
12/19/2012 | CN102824526A Anti-tumor plant extract composition and preparation method and application thereof |
12/19/2012 | CN102824525A Preparation method of asparagus filicinus steroid total saponin extract |
12/19/2012 | CN102824517A Application of suoquan capsules in preparing medicines for suppressing OS-732 cell proliferation |
12/19/2012 | CN102824515A Application of Reduqing pills in preparation of medicine for inhibiting A-204 cell proliferation |
12/19/2012 | CN102824509A Mode for treating cancer and acquired immune deficiency syndrome by Chinese aloe wine food therapy |
12/19/2012 | CN102824417A New method for treating helicobacter pylori related diseases |
12/19/2012 | CN102824406A Application of longdan tongluo capsule in preparation of pharmaceuticals for inhibiting MJ cell proliferation |
12/19/2012 | CN102824404A Traditional Chinese medicinal composition as well as preparation process and application thereof |
12/19/2012 | CN102824402A Application of semen euporbiae pulveraqtum in preparation of pharmaceuticals for inhibiting OS-732 cell proliferation |
12/19/2012 | CN102824398A Application of sedum purpureum for preparation of pharmaceuticals for treating tumors |
12/19/2012 | CN102824394A Method for synchronously extracting and separating icariin and icarisid II from herba epimedii |
12/19/2012 | CN102824392A Method for extracting florilenalin from helenium bigelovii leaves |
12/19/2012 | CN102824386A Application of Chinese aralis bark total saponins in antitumor |
12/19/2012 | CN102824385A Aralia tengyuch euonymus bark total saponin and preparation method and application thereof |
12/19/2012 | CN102824384A Method for extracting total lactones from allamanda schottii |